Class information for:
Level 2: FOOD AND DRUG LAW JOURNAL//GENERIC SUBSTITUTION//DIRECT TO CONSUMER ADVERTISING

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1294 8163 32.9 42%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
576 13579 FOOD AND DRUG LAW JOURNAL//CIENCIA & SAUDE COLETIVA//SAUDE E SOCIEDADE

Classes in level below (level 1)


ID, lev. below Publications Label for level below
5622 1532 CONFLICT OF INTEREST//CONFLICTS OF INTEREST//DRUG SAMPLES
5869 1495 GENERIC SUBSTITUTION//GENERIC DRUGS//REFERENCE PRICING
15717 626 FOOD AND DRUG LAW JOURNAL//HUMANITARIAN DEVICE EXEMPTION//PREMARKET APPROVAL
16529 584 CLINICAL TRIAL RISK//CONTINUOUS IMPROVEMENT//STRATEGIE IND
17331 541 ORPHAN DRUGS//RARE DISEASES//OFF ORPHAN PROD DEV
17577 529 STEM CELL TOURISM//PROGRAM STEM CELLS SOC//UK STEM CELL BANK
17606 527 DIRECT TO CONSUMER ADVERTISING//DTCA//DTC ADVERTISING
17877 515 COMPULSORY LICENSING//ACCESS TO MEDICINES//DOHA DECLARATION
18530 482 DRUG LAG//OFF PHARMACEUT IND//JAPANESE CLINICAL TRIALS
19075 457 PHARMACEUTICALISATION//CRHAM//CORPORATE BIAS
21917 344 FOOD AND DRUG LAW JOURNAL//ADVOCACY NETWORK//AGR LAW
25884 222 PROGRAM LIFE SCI ETH POLICY//MCLAUGHLIN ROTMAN GLOBAL HLTH//ESRC INNOGEN
26997 198 INTELLECTUAL PROPERTY PROGRAM//CARDIORENAL DRUGS//FOOD DRUG GRP
32236 111 BIOCHEMICAL ENGINEERING SCIENCE//IF I CLERSE//UVB

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FOOD AND DRUG LAW JOURNAL Journal 420 55% 6% 526
2 GENERIC SUBSTITUTION Author keyword 89 75% 1% 65
3 DIRECT TO CONSUMER ADVERTISING Author keyword 66 65% 1% 62
4 CONFLICT OF INTEREST Author keyword 63 32% 2% 163
5 GENERIC DRUGS Author keyword 48 42% 1% 88
6 PHARMACEUTICAL INDUSTRY Author keyword 42 22% 2% 165
7 ORPHAN DRUGS Author keyword 40 46% 1% 64
8 GENERIC MEDICINES Author keyword 37 73% 0% 29
9 DRUG INDUSTRY Author keyword 36 44% 1% 63
10 REFERENCE PRICING Author keyword 31 73% 0% 24

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 GENERIC SUBSTITUTION 89 75% 1% 65 Search GENERIC+SUBSTITUTION Search GENERIC+SUBSTITUTION
2 DIRECT TO CONSUMER ADVERTISING 66 65% 1% 62 Search DIRECT+TO+CONSUMER+ADVERTISING Search DIRECT+TO+CONSUMER+ADVERTISING
3 CONFLICT OF INTEREST 63 32% 2% 163 Search CONFLICT+OF+INTEREST Search CONFLICT+OF+INTEREST
4 GENERIC DRUGS 48 42% 1% 88 Search GENERIC+DRUGS Search GENERIC+DRUGS
5 PHARMACEUTICAL INDUSTRY 42 22% 2% 165 Search PHARMACEUTICAL+INDUSTRY Search PHARMACEUTICAL+INDUSTRY
6 ORPHAN DRUGS 40 46% 1% 64 Search ORPHAN+DRUGS Search ORPHAN+DRUGS
7 GENERIC MEDICINES 37 73% 0% 29 Search GENERIC+MEDICINES Search GENERIC+MEDICINES
8 DRUG INDUSTRY 36 44% 1% 63 Search DRUG+INDUSTRY Search DRUG+INDUSTRY
9 REFERENCE PRICING 31 73% 0% 24 Search REFERENCE+PRICING Search REFERENCE+PRICING
10 BRAND NAME DRUG 31 92% 0% 12 Search BRAND+NAME+DRUG Search BRAND+NAME+DRUG

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PHARMACEUTICAL INDUSTRY 111 29% 4% 330
2 DRUG COMPANIES 77 65% 1% 73
3 CONFLICTS OF INTEREST 74 32% 2% 189
4 GIFTS 68 50% 1% 98
5 PRESCRIPTION DRUGS 44 29% 2% 128
6 INTEREST POLICIES 33 83% 0% 19
7 GENERIC ENTRY 32 88% 0% 15
8 PHARMACEUTICAL SALES REPRESENTATIVES 29 75% 0% 21
9 PHARMACEUTICAL ADVERTISEMENTS 28 64% 0% 27
10 REPRESENTATIVES 26 25% 1% 91

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FOOD AND DRUG LAW JOURNAL 420 55% 6% 526
2 NEW GENETICS AND SOCIETY 6 13% 1% 42
3 THERAPEUTIC INNOVATION & REGULATORY SCIENCE 4 13% 0% 30
4 BIOTECHNOLOGY LAW REPORT 4 16% 0% 23
5 BIOSOCIETIES 2 11% 0% 18
6 JOURNAL OF INTELLECTUAL PROPERTY RIGHTS 1 11% 0% 10

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Physicians and the pharmaceutical industry - Is a gift ever just a gift? 2000 640 39 95%
Scope and impact of financial conflicts of interest in biomedical research - A systematic review 2003 782 55 60%
The cost of drug development: A systematic review 2011 59 8 100%
Drug discovery in pharmaceutical industry: productivity challenges and trends 2012 50 12 67%
Models for open innovation in the pharmaceutical industry 2013 15 3 100%
Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease A Systematic Review and Meta-analysis 2008 119 66 55%
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival 2012 82 21 29%
Industry sponsorship and research outcome 2012 43 112 52%
Industry Relationships Among Academic Institutional Review Board Members Changes From 2005 Through 2014 2015 1 14 93%
Orphan drug development: an economically viable strategy for biopharma R&D 2012 25 11 73%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 OFF ORPHAN PROD DEV 17 70% 0.2% 14
2 CRHAM 17 100% 0.1% 8
3 TUFTS STUDY DRUG DEV 16 48% 0.3% 25
4 EDMOND J SAFRA ETH 15 44% 0.3% 27
5 SCI TECHNOL INNOVAT NEGLECTED DIS 12 86% 0.1% 6
6 OFF PHARMACEUT IND 11 100% 0.1% 6
7 PROGRAM LIFE SCI ETH POLICY 8 70% 0.1% 7
8 STUDY DRUG DEV 8 42% 0.2% 15
9 PROGRAM STEM CELLS SOC 7 64% 0.1% 7
10 MCLAUGHLIN ROTMAN GLOBAL HLTH 7 23% 0.3% 25

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000014004 SILDENAFIL ANALOGUE//COUNTERFEIT MEDICINES//SUBSTANDARD DRUGS
2 0.0000011476 RESEARCH MISCONDUCT//PEER REVIEW//RESPONSIBLE CONDUCT OF RESEARCH
3 0.0000011099 JOURNAL OF THE COPYRIGHT SOCIETY OF THE USA//IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW//IIC-INTERNATIONAL REVIEW OF INDUSTRIAL PROPERTY AND COPYRIGHT LAW
4 0.0000010956 EQ 5D//HEALTH TECHNOLOGY ASSESSMENT//INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
5 0.0000009705 EVIDENCE BASED MEDICINE//BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION//PUBLICATION BIAS
6 0.0000007873 DOUBLE DATA ENTRY//RISK BASED MONITORING//SOURCE DATA VERIFICATION
7 0.0000007682 INFORMED CONSENT//RESEARCH ETHICS//MEDICAL ETHICS
8 0.0000006427 HEALTH POLICY & SERVICES//HEALTH AFFAIRS//INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING
9 0.0000006418 BEERS CRITERIA//PHARMACOVIGILANCE//MEDICATION RECONCILIATION
10 0.0000005907 AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//AMERICAN JOURNAL OF HOSPITAL PHARMACY//COMMUNITY PHARMACY